Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories Narrows FY 2012 EPS Guidance


Wednesday, 17 Oct 2012 07:44am EDT 

Abbott Laboratories narrowed fiscal 2012 earnings per share (EPS) guidance to a range $5.06 to $5.08 from $5.00 to $5.10. Including specified items, projected earnings per share under GAAP would be $3.83 to $3.85 for the full-year 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $5.06 for fiscal 2012. 

Company Quote

42.11
-0.21 -0.50%
22 Aug 2014